Menu
Israel and Senegal announce end to crisis

Israel and Senegal announce end to …

​Israel will immediately ...

Statements by PM Netanyahu and US President Donald Trump

Statements by PM Netanyahu and US P…

​PM Netanyahu: I want to ...

WJC President Lauder commends Comerica for closing anti-Israel group’s bank account

WJC President Lauder commends Comer…

WJC, World Jewish Congres...

Lt. Gen. Gadi Eizenkot, Chief of the General Staff, Memorial Day Message

Lt. Gen. Gadi Eizenkot, Chief of th…

In these moments we stand...

Holocaust Martyrs' and Heroes' Remembrance Day 2017

Holocaust Martyrs' and Heroes' Reme…

​The Holocaust Martyrs' a...

University of Haifa and Rambam Hospital Unveil Partnership and Plans for Twenty-Story ‘Medical Discovery Tower’

University of Haifa and Rambam Hosp…

Strategic partnership bet...

In landmark ruling, US court allows heirs of Jewish art dealers to sue Germany for restitution

In landmark ruling, US court allows…

WJC, A district court in ...

230 Ukrainian Immigrants Arrive in Israel for Passover, Part of Effort to Rescue Embattled Jews

230 Ukrainian Immigrants Arrive in …

JERUSALEM, More than 200 ...

Ambassadors Against BDS: 2,000 gather at United Nations HQ in New York in support of Israel

Ambassadors Against BDS: 2,000 gath…

The World Jewish Congress...

Prev Next
A+ A A-

Teva Announces: President and CEO. Dr. Jeremy Levin steps down as President and CEO, Eyal Desheh, Teva's Group EVP & Chief Financial Officer, named interim President and CEO Featured

JERUSALEM, Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announced today that its Board of Directors has agreed with Dr. Jeremy Levin that he will step down as President and Chief Executive Officer. The Board has named Eyal Desheh, Teva's Executive Vice President and Chief Financial Officer, to fill the role of President and Chief Executive Officer on an interim basis, effective immediately, and it has formed a committee that will promptly begin to search for a permanent successor. 

Dr. Phillip Frost, Chairman of the Board, stated “On behalf of the entire Board of Directors, I would like to thank Dr. Jeremy Levin for his meaningful contribution to Teva during the last two years. The Board and management team are fully committed to the implementation of Teva's strategy, including the development of new compounds, making strategic acquisitions, forming joint ventures and the planned acceleration of the Company’s cost reduction program.”

“Since I joined Teva, we have made tremendous progress in setting a new course for the Company,” said Dr. Jeremy Levin. "I wish the Company and its people, who I respect greatly, every success. I look forward to pursuing new opportunities where I can continue to apply my experience and contribute to the evolution of the global pharmaceutical industry.”

"I have full confidence in the ability of Teva's management and employees to achieve our goals and execute the strategy laid out for the Company,” said Eyal Desheh, who has served at Teva for over 12 years, including the last five as Chief Financial Officer. “My colleagues in Teva's management and I will continue to drive execution and results in full collaboration with our Board of Directors, for the benefit of our patients, shareholders, customers and employees."

As previously scheduled, Teva will report its third quarter 2013 financial results on October 31, 2013.
Last modified onMonday, 09 January 2017 15:10

Leave a comment

Make sure you enter the (*) required information where indicated. HTML code is not allowed.

back to top
40% off 4 or more products. Enter code 40SPRING at checkout. Get a discount with a minimum purchase at PaulFredrick.com
Travel Deals to top Destinations. Get yours now

Sections

Jewish Traditions

About Us

Community

Cooperations

Follow Us